8-K/A

AMENDMENT TO FORM 8-K

Company: ABVC BIOPHARMA, INC.
Filed: January 29, 2016
Period of Report: January 4, 2016
Accession Number: 0001014897-16-000446

View Document ↗ View on SEC.gov ↗